Today's biopharmaceutical sector, emmm, how to put it, I really can't understand why Moderna dipped a little, with loans and collaborations already announced, it just gave you a hesitant -0.57%. Jefferies' target price is a bit painfully low, although they are quite pragmatic, it's just frustrating. Rezolute is ridiculous, it plummeted terribly yesterday, and today it surged again by 28 points—who can handle that? But with Phase 3 already failed, how dare they keep the buy rating? Not sure if the law firm will stir up trouble, I don’t believe it but still feel itchy to act. Regencell... the DOJ’s move added some pressure; it was already volatile day by day, now it’s just dizzying. Vor luckily rose a bit, but there’s no news, so I don’t know why it went up. Ah, the market is just this absurd 🤷‍♂️